Studies, including those published in The Lancet , highlight GLP-1s broader metabolic benefits, reinforcing its role not just in weight management but in systemic inflammation reduction
Compared to semaglutide (Ozempic, Wegovy), retatrutide produces more GI side effects at doses that achieve equivalent or greater weight loss
Arthritis Rheumatol 76(2024)
b) Another study published in the European Journal of Pharmacology showed that BPC-157 protected against calcium imbalance induced by certain toxins, highlighting its potential therapeutic value in maintaining calcium homeostasis
Forty three pouchees were followed and it was found that GLP-1 treatment resulted in a decrease in the risk of recurrent pouchitis from 53% to 26%, a decreased risk of 50%
Improved comorbidity adjustment for predicting mortality in Medicare populations